Is a $10.6 Billion Biotech Buyout Enough to Lift the Whole Tape?
GSK agreed to acquire Nuvalent for $124 per share in a $10.6 billion deal,...
GSK agreed to acquire Nuvalent for $124 per share in a $10.6 billion deal,...
U.S. equities opened Friday, April 17, 2026 with the S&P 500 holding near...